Clinical Trial Update: Efficacy and Safety of Low Dose Thalidomide in Transfusion Dependent Thalassemia [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 trial evaluating the efficacy and safety of low-dose thalidomide in transfusion-dependent thalassemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thalassemia

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: Blood Diseases Clinic | Conditions: Thalassemia | Phase 2, Phase 3 | Status: COMPLETED